Bank Of Montreal Atreca, Inc. Transaction History

Bank Of Montreal

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.56 - $3.25 $24,587 - $51,223	-15,761 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.61 - $5.2 $3,010 - $9,724	-1,870 Reduced 10.61%	15,761 $56,000
Q4 2021 Feb 11, 2022	BUY	$2.87 - $6.29 $50,600 - $110,898	17,631 New	17,631 $54,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.